133 related articles for article (PubMed ID: 8844876)
1. Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model.
Abelson JL; Weg JG; Nesse RM; Curtis GC
Psychoneuroendocrinology; 1996 May; 21(4):375-90. PubMed ID: 8844876
[TBL] [Abstract][Full Text] [Related]
2. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
Abelson JL; Liberzon I; Young EA; Khan S
Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine responses to psychological stress in adolescents with anxiety disorder.
Gerra G; Zaimovic A; Zambelli U; Timpano M; Reali N; Bernasconi S; Brambilla F
Neuropsychobiology; 2000; 42(2):82-92. PubMed ID: 10940763
[TBL] [Abstract][Full Text] [Related]
4. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
Abelson JL; Khan S; Liberzon I; Young EA
Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
[TBL] [Abstract][Full Text] [Related]
5. Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic.
Abelson JL; Nesse RM; Weg JG; Curtis GC
Psychosom Med; 1996; 58(4):302-13. PubMed ID: 8827792
[TBL] [Abstract][Full Text] [Related]
6. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence.
Ehrenreich H; Schuck J; Stender N; Pilz J; Gefeller O; Schilling L; Poser W; Kaw S
Alcohol Clin Exp Res; 1997 Oct; 21(7):1285-93. PubMed ID: 9347091
[TBL] [Abstract][Full Text] [Related]
7. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India.
Chittiprol S; Kumar AM; Satishchandra P; Taranath Shetty K; Bhimasena Rao RS; Subbakrishna DK; Philip M; Satish KS; Ravi Kumar H; Kumar M
Psychoneuroendocrinology; 2008 Jan; 33(1):30-40. PubMed ID: 17993249
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine responses to experimentally-induced psychological stress in healthy humans.
Gerra G; Zaimovic A; Mascetti GG; Gardini S; Zambelli U; Timpano M; Raggi MA; Brambilla F
Psychoneuroendocrinology; 2001 Jan; 26(1):91-107. PubMed ID: 11070337
[TBL] [Abstract][Full Text] [Related]
9. Doxapram-induced panic attacks and cortisol elevation.
Gutman DA; Coplan J; Papp L; Martinez J; Gorman J
Psychiatry Res; 2005 Feb; 133(2-3):253-61. PubMed ID: 15741000
[TBL] [Abstract][Full Text] [Related]
10. Respiratory irregularity and stress hormones in panic disorder: exploring potential linkages.
Abelson JL; Khan S; Lyubkin M; Giardino N
Depress Anxiety; 2008; 25(10):885-7. PubMed ID: 17557312
[TBL] [Abstract][Full Text] [Related]
11. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
Ströhle A; Holsboer F; Rupprecht R
Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
[TBL] [Abstract][Full Text] [Related]
12. Rodent doxapram model of panic: behavioral effects and c-Fos immunoreactivity in the amygdala.
Sullivan GM; Apergis J; Gorman JM; LeDoux JE
Biol Psychiatry; 2003 May; 53(10):863-70. PubMed ID: 12742673
[TBL] [Abstract][Full Text] [Related]
13. Lack of specific association between panicogenic properties of caffeine and HPA-axis activation. A placebo-controlled study of caffeine challenge in patients with panic disorder.
Masdrakis VG; Markianos M; Oulis P
Psychiatry Res; 2015 Sep; 229(1-2):75-81. PubMed ID: 26243374
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine effects of diazepam in panic and generalized anxiety disorders.
Roy-Byrne PP; Cowley DS; Hommer D; Ritchie J; Greenblatt D; Nemeroff C
Biol Psychiatry; 1991 Jul; 30(1):73-80. PubMed ID: 1654136
[TBL] [Abstract][Full Text] [Related]
15. Psychoimmunoendocrine aspects of panic disorder.
Brambilla F; Bellodi L; Perna G; Battaglia M; Sciuto G; Diaferia G; Petraglia F; Panerai A; Sacerdote P
Neuropsychobiology; 1992; 26(1-2):12-22. PubMed ID: 1335559
[TBL] [Abstract][Full Text] [Related]
16. Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4.
Eser D; Leicht G; Baghai T; Pogarell O; Schüle C; Karch S; Nothdurfter C; Rupprecht R; Mulert C
J Psychiatr Res; 2009 Jan; 43(4):393-400. PubMed ID: 18534623
[TBL] [Abstract][Full Text] [Related]
17. Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans.
Monteleone P; Beinat L; Tanzillo C; Maj M; Kemali D
Neuroendocrinology; 1990 Sep; 52(3):243-8. PubMed ID: 2170852
[TBL] [Abstract][Full Text] [Related]
18. CO2 challenge induced HPA axis activation in panic.
van Duinen MA; Schruers KR; Maes M; Griez EJ
Int J Neuropsychopharmacol; 2007 Dec; 10(6):797-804. PubMed ID: 17076937
[TBL] [Abstract][Full Text] [Related]
19. Pivagabine effects on neuroendocrine responses to experimentally-induced psychological stress in humans.
Gerra G; Zaimovic A; Giusti F; Baroni MC; Delsignore R; Raggi MA; Brambilla F
Behav Brain Res; 2001 Jul; 122(1):93-101. PubMed ID: 11287080
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition.
Otte C; Moritz S; Yassouridis A; Koop M; Madrischewski AM; Wiedemann K; Kellner M
Neuropsychopharmacology; 2007 Jan; 32(1):232-8. PubMed ID: 17035932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
